Ads
related to: monoclonal antibody
Search results
Critics Say FDA's Use of Surrogate Markers Falling Short
Medscape· 4 days agoAs the FDA's use of surrogate endpoints in the drug approval process is increasing, researchers are...
Why Lilly And Novo Nordisk Will Keep Dominating The Market For Blockbuster GLP-1 Drugs
Forbes· 6 days agoA survey released by KFF this week found that one in eight adults said they’ve taken a GLP-1 drug,...
BioMarin cutting about 170 jobs after shuffling drug portfolio - San Francisco Business Times
The Business Journals· 6 days agoMost of the employees hit by the cuts were told Tuesday, the company (NASDAQ: BMRN) said. BioMarin...
Molecular fingerprinting of biological nanoparticles with a label-free optofluidic platform - Nature...
Nature· 6 days agoIn this work, we fulfilled the requirements for label-free molecular fingerprinting of heterogeneous nanoparticle suspensions by focussing our efforts around three main concepts: (i) large FOV ...
What to know about the COVID-19 FLiRT variant as it spreads in Connecticut ahead of summer
The News-Times· 6 days agoA new group of COVID-19 variants called “FLiRT” are rapidly becoming the dominant mutations of the...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 2 days agoAmgen (NASDAQ:AMGN) and AstraZeneca today announced the results of the Phase 2a COURSE trial evaluating Tezspire® (tezepelumab-ekko) in people with moderate to very severe chronic obstructive ...
Intel upgraded, Texas Instruments initiated: Wall Street's top analyst calls
The Fly via Yahoo Finance· 5 days agoH.C. Wainwright initiated coverage of Dianthus Therapeutics (DNTH) with a Buy rating and $40 price...
Eisai initiates rolling Biologics License Application to US FDA for Leqembi® (lecanemab-irmb) for...
FOX 59 Indianapolis· 6 days agoBioArctic AB's (publ) (NASDAQ STOCKHOLM: BIOA B) partner Eisai announced today that they have...
ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent Highlights
Digital Journal· 6 days agoTop-line data from first-in-human Phase 1a clinical trial of PMN310 as a treatment for Alzheimer’s disease on track for mid-2024CAMBRIDGE, Massachusetts and TORONTO, Ontario, May 14, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a
Sleep apnea is linked to changes in verbal memory
UC Irvine Today· 4 days agoUCI News highlighted a newly published study led by Bryce Mander, PhD, a UCI MIND faculty member and associate professor of psychiatry and human behavior, showing a link between sleep apnea ...